Vaxxas
Latest round
- Series D
Last raised
- Aug 2025
Total raised
- $124M
Investors
- 10
About Vaxxas
Founded in 2011 and based in Sydney, Australia, Vaxxas Pty Ltd develops and commercializes a needle-free vaccine delivery system. The company focuses on enhancing the performance of existing and future vaccines through the development and commercialization of the company's novel vaccine delivery technology - the Nanopatch™. Vaxxas Pty Ltd offers research and development of vaccines with the goal of improving health conditions.
Who invested in Vaxxas
10 investors across 12 rounds
See all investors in Vaxxas
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Aug 25, 2025
Amount
$49M
Investors
Series C
Dec 5, 2022
Amount
$23M
Investors
Series C
May 1, 2020
Amount
$14M
Investors
Series B
Aug 20, 2019
Amount
$5.7M
Investors
Series B
Apr 30, 2018
Amount
$6.9M
Investors
Series B
May 31, 2017
Amount
$2.6M
Investors
Series B
Apr 20, 2016
Amount
$3.9M
Investors
Series B
Feb 27, 2015
Amount
$6.1M
Investors
Series A
Jun 12, 2014
Amount
$2.1M
Investors
Series A
Jun 14, 2013
Amount
$1.9M
Investors
Series A
Apr 24, 2012
Amount
$5.9M
Investors
Series A
Sep 13, 2011
Amount
$2.4M
Investors
Questions about Vaxxas
Who invested in Vaxxas?
Vaxxas has 10 investors on record across 12 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vaxxas raised?
Vaxxas has raised 12 venture rounds. Sign up free to see how much each round raised and the total.
When did Vaxxas last raise money?
Vaxxas's most recent round on record is a Series D, in Aug 2025.
What does Vaxxas do?
Founded in 2011 and based in Sydney, Australia, Vaxxas Pty Ltd develops and commercializes a needle-free vaccine delivery system.
Where is Vaxxas headquartered?
Vaxxas is headquartered in Australia.
Which VCs invest in companies like Vaxxas?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Vaxxas's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Vaxxas? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.